Skip to main content

Table 4 Overall and phase of care net cost of health care resources by stage at diagnosis and treatment type for the esophageal adenocarcinoma cohort, 2003–2011

From: Estimates and predictors of health care costs of esophageal adenocarcinoma: a population-based cohort study

Cost category

Overall

 

Initial Phase

 

Continuing Care Phase

 

Terminal Phase

 

Meana (95% CI)

N (Cases)

Meana (95% CI)

N (Cases)

Meana (95% CI)

N (Cases)

Meana (95% CI)

Stage at EAC diagnosis

 Stage 0-I

$5094 ($2659–$7529)

102

$804 ($626–$982)

64

$646 ($481–$810)

126

$4249 ($1789–$6710)

 Stage II

$6192 ($5368–$7015)

282

$999 ($887–$1111)

161

$696 ($600–$791)

416

$5426 ($4574–$6277)

 Stage III

$7413 ($6679–$8147)

273

$1254 ($1142–$1366)

136

$708 ($565–$851)

451

$6652 ($5879–$7425)

 Stage IV

$9978 ($9093–$10,864)

222

$1010 ($887–$1134)

74

$620 ($461–$780)

930

$10,000 ($9106–$10,894)

Type of EAC treatment

 Surgery alone

$7785 ($6667–$8903)

361

$996 ($856–$1135)

215

$868 ($690–$1046)

533

$6937 ($5802–$8071)

 Chemotherapy alone

$8607 ($7565–$9650)

161

$1109 ($935–$1282)

86

$590 ($466–$715)

338

$8168 ($7091–$9245)

 Radiotherapy alone

$7998 ($7095–$8901)

228

$1330 ($1187–$1474)

118

$630 ($518–$742)

405

$7285 ($6344–$8225)

 Surgery + chemotherapy

$5801 ($4751–$6850)

81

$1089 ($862–$1316)

52

$878 ($634–$1123)

118

$4832 ($3710–$5954)

 Surgery + radiotherapy

$12,417 ($2067–$22,767)

–

$1080 ($494–$1667)

–

$170 (−$200–$539)

6

$12,237 ($1541–$22,933)

 Chemotherapy + radiotherapy

$7671 ($6023–$9320)

68

$1129 ($909–$1350)

40

$846 ($650–$1042)

109

$6849 ($5107–$8590)

 Surgery + chemotherapy + radiotherapy

$4743 ($1755–$7731)

7

$1323 ($757–$1890)

–

$236 ($111–$362)

7

$3519 ($684–$6354)

 No treatment

$10,152 ($9431–$10,873)

377

$765 ($688–842)

136

$318 ($243–$393)

1495

$10,238 ($9512–$10,965)

  1. aMean health care costs are expressed in 2016 Canadian dollars per 30 patient-days. ‘–’, counts less than six are suppressed
  2. EAC esophageal adenocarcinoma, CI confidence intervals